Human metapneumovirus phosphoprotein (hMPV P)

The Human metapneumovirus (hMPV) phosphoprotein (P) is a vital non-catalytic subunit of the viral RNA-dependent RNA polymerase complex (UniProt Q91L29). It functions primarily as a molecular bridge, tethering the large polymerase protein (L) to the nucleoprotein (N)-RNA template to enable viral transcription and replication (PubMed 31413131). Beyond its role in the polymerase complex, the P protein acts as a chaperone for monomeric, RNA-free nucleoprotein (N0), ensuring it remains available for specific encapsidation of the nascent viral genome (PubMed 25122778). Structurally, the protein is characterized by a central oligomerization domain that forms a homotetramer, flanked by highly flexible, intrinsically disordered regions (PubMed 31413131). These disordered regions are crucial for mediating interactions with various viral and host factors, making the protein a central hub in the hMPV life cycle. In the context of disease, hMPV is a leading cause of pediatric bronchiolitis and pneumonia, particularly in infants, the elderly, and the immunocompromised (CDC, 2023). As there are currently no approved vaccines or specific antivirals for hMPV, the P protein has emerged as a high-priority therapeutic target. Experimental strategies focus on small molecules or peptidomimetics that disrupt the essential N-P or L-P protein-protein interactions (PubMed 25122778). Successfully targeting these interfaces could effectively halt viral replication and alleviate the burden of severe respiratory disease.

Other names

PhosphoproteinP proteinhMPV P proteinPolymerase cofactor P

Inhibition of the protein-protein interaction between the phosphoprotein and the nucleoprotein (N-P interaction), or between the phosphoprotein and the large polymerase protein (L-P interaction), thereby disrupting viral RNA synthesis (PubMed 25122778).